SEC Form 4 research
| Issuer | HALOZYME THERAPEUTICS INC |
|---|---|
| Tickers | HALO, HTI |
| Reporting owners | 45 |
| Officers and directors | 21 |
| Last public filing | 2026-10-08 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-08 | 2026-10-07 | Torley Helen | S | 900 | $112.78 | Not reported |
| 2026-10-08 | 2026-10-07 | Torley Helen | S | 10,300 | $111.84 | Not reported |
| 2026-10-08 | 2026-10-07 | Torley Helen | S | 8,600 | $111.03 | Not reported |
| 2026-10-08 | 2026-10-06 | Torley Helen | S | 1,780 | $110.81 | Not reported |
| 2026-10-08 | 2026-10-06 | Torley Helen | S | 9,920 | $109.89 | Not reported |
| 2026-10-08 | 2026-10-06 | Torley Helen | S | 6,000 | $109.33 | Not reported |
| 2026-10-08 | 2026-10-06 | Torley Helen | S | 2,300 | $107.9 | Not reported |
| 2026-10-08 | 2026-10-08 | Torley Helen | S | 200 | $110.51 | Not reported |
| 2026-10-08 | 2026-10-08 | Torley Helen | S | 11,900 | $110 | Not reported |
| 2026-10-08 | 2026-10-08 | Torley Helen | S | 3,090 | $108.91 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.